Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Paclitaxel-Carboplatin Combo Promising Against Rare Uterine Cancer
Link ID 25423
Title Paclitaxel-Carboplatin Combo Promising Against Rare Uterine Cancer
Url http://www.medscape.com/viewarticle/721945?src=rss
Description An outpatient regimen of paclitaxel and carboplatin has activity against carcinosarcoma of the uterus, researchers report in the April 26th online issue of the Journal of Clinical Oncology. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date May 19, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Pathophysiology and Risk Factors for Gout: Update From ACR 2008
  Herbert Baraf, MD, summarizes updates on gout pathophysiology and its risk factors, as illustrated by data presented at ACR 2008.
Medscape Rheumatology
Category:   Articles > Pharmacists


2. Anticoagulant Use in Long-Term Care Can Be Substantially Improved
  Monitoring and control of anticoagulants can be less than optimal in long-term care settings and, surprisingly, may also be less effective than in outpatient settings, according to a study by Canadian researchers published online in BioMed Central Geriatrics on July 3. The authors recommend addressing this with improved physician education and pharmacy monitoring. Reuters Health Information
Category:   Articles > Pharmacists


3. Bone Health Management Suboptimal in Prostate Cancer Patients
  Few men with prostate cancer undergoing androgen-deprivation therapy (ADT) are told about effects on bone density, and prevention efforts are not usual, according to a report in the March issue of BJU International. Reuters Health Information
Category:   Articles > Pharmacists


4. Longer Hormone Therapy May Improve Outcomes in Advanced Prostate Cancer
  Androgen suppression of locally advanced prostate cancer appears to be more successful when treatment is prolonged, according to Canadian and US researchers. Reuters Health Information
Category:   Articles > Pharmacists


5. Lapatinib Effective When Breast Tumors Express HER2 and P95HER2
  Lapatinib (Tykerb) is effective against breast cancers that express human epidermal growth factor receptor 2 (HER2), whether or not the tumors also express a truncated HER2 receptor called p95HER2, new studies show. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS